Skip to content
Search

Latest Stories

70 per cent of community pharmacies still waiting for government nod to start Covid booster jab

Nearly 70 per cent of community pharmacies in England that offered to participate in the Covid-19 booster programme are still waiting for approval or have been refused, ministers admitted on Monday (December 13).

The Liberal Democrats’ health spokesperson, Daisy Cooper, exposed the low approval rate and long delays through a written parliamentary question to the health secretary as to "how many community pharmacies were providing Covid-19 vaccinations as of 3 December 2021."


Maggie Throup MP New pharmacy minister Maggie Throup MP. Image courtesy: maggiethroup.com

In response vaccines minister Maggie Throup said: “As of the end of September 2021, 4,733 contractors submitted 5,376 expressions of interest to take part in the booster vaccination programme, with 1,454 accepted.”

The figures show an approval rate of 30.7 per cent.

She added: “As of 3 December 2021, 1,336 community pharmacy vaccination sites were actively providing the service.”

Some applications were decided by NHS England rather than the Department of Health and Social Care (DHSC).

Acknowledging long wait for giving a green signal to community pharmacies, Throup said: “Since 1 August, the shortest period from receipt of application to a pharmacy providing the Covid-19 vaccination service was 14 days, the longest was 78 days, with an average of 44 days.”

Sector reacts

Reacting to the data released by the minister, many from the sector have called on the government to increase the rate of approval for pharmacies by being less rigid in its requirements.

Alastair Buxton, director of NHS Services at Pharmaceutical Services Negotiating Committee (PSNC), said: “In community pharmacies we have a network of thousands of healthcare locations on the high street, many of whom are ready, willing and able to offer Covid vaccinations."

He added that many pharmacies are capable and willing to “support the NHS in delivering the ambitious booster campaign.”

“Pharmacy owners are at a loss to understand why nearly 4,000 sites which they felt could offer Covid vaccinations are not now being used to do so – this could help meet the prime minister’s targets, ease pressure on General Practice, and help improve accessibility for the public.

“We urge the NHS to revisit its policy on pharmacy vaccination sites and allow more pharmacies to play their part in this ongoing national health emergency.”

Insisting on the potential central role that community pharmacies could play in vaccination drive, Nick Kaye, vice chair of the National Pharmacy Association (NPA) said: “Thousands more pharmacies have offered to vaccinate and it’s scandalous that so many have been turned down.

“The NHS should be aiming to commission maximum provision, as this is a moment of national emergency.

“The queues outside current sites tell their own story.

“All existing pharmacy applications to become vaccine centres should be reconsidered immediately.  Even if it’s too late for most to be brought on line for the current burst, let’s get the sites approved now so that they can be stood up swiftly whenever the need arises.”

THORRUN GOVIND Thorrun Govind, chair of RPS in England

Thorrun Govind, Royal Pharmaceutical Society chair in England, told The Guardian: “On 13 December just 1,500 community pharmacies delivered 44 per cent of all the Covid booster jabs in England – 185,000 out of a total of 418,000 booster jabs – which is an extraordinary feat from an already exhausted workforce.

“The workforce is under enormous pressure and is delivering boosters at an incredible rate, but must not be shackled in the attempt by unnecessary officialdom.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less